Cargando…

Growth, Tolerance, and Compliance of Infants Fed an Extensively Hydrolyzed Infant Formula with Added 2′-FL Fucosyllactose (2′-FL) Human Milk Oligosaccharide

Background: The purpose of this study was to evaluate the growth, tolerance and compliance effects of an extensively hydrolyzed formula with added 2′-FL in an intended use population of infants. Methods: A non-randomized, single-group, multicenter study was conducted. Infants (0–60 days of age) with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramirez-Farias, Carlett, Baggs, Geraldine E., Marriage, Barbara J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827526/ https://www.ncbi.nlm.nih.gov/pubmed/33435326 http://dx.doi.org/10.3390/nu13010186

Ejemplares similares

Infants Fed a Lower Calorie Formula With 2′FL Show Growth and 2′FL Uptake Like Breast-Fed Infants
por: Marriage, Barbara J., et al.
Publicado: (2015)

Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula
por: Vandenplas, Yvan, et al.
Publicado: (2018)

Review of the Clinical Experiences of Feeding Infants Formula Containing the Human Milk Oligosaccharide 2′-Fucosyllactose
por: Reverri, Elizabeth J., et al.
Publicado: (2018)

Comparison of Growth of Healthy Term Infants Fed Extensively Hydrolyzed Protein- and Amino Acid-Based Infant Formulas
por: Borschel, Marlene W., et al.
Publicado: (2018)

Infants Fed Breastmilk or 2′-FL Supplemented Formula Have Similar Systemic Levels of Microbiota-Derived Secondary Bile Acids
por: Hill, David R., et al.
Publicado: (2023)

Safety of the extension of use of 2’‐fucosyllactose (2’‐FL) and lacto‐N‐neotetraose (LNnT) as novel foods in food supplements for infants pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2022)

Safety of the extension of use of 2′‐fucosyllactose (2′‐FL) as a novel food pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2023)

Determination of 2′-Fucosyllactose and Lacto-N-neotetraose in Infant Formula
por: Austin, Sean, et al.
Publicado: (2018)

Safety of 3‐FL (3‐Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2021)

Is the Macronutrient Intake of Formula-Fed Infants Greater Than Breast-Fed Infants in Early Infancy?
por: Hester, Shelly N., et al.
Publicado: (2012)

2′-Fucosyllactose Is Well Tolerated in a 100% Whey, Partially Hydrolyzed Infant Formula With Bifidobacterium lactis: A Randomized Controlled Trial
por: Storm, Heidi M., et al.
Publicado: (2019)

A Trp53(fl/fl)Pten(fl/fl) mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging
por: Buchakjian, Marisa R., et al.
Publicado: (2017)

Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal
por: James, Kieran, et al.
Publicado: (2019)

Safety of the extension of use of 2’‐fucosyllactose/difucosyllactose (2’‐FL/DFL) mixture and lacto‐N‐tetraose (LNT) as novel foods in food supplements for infants pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2022)

Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the Kras(G12D+); p53(fl/fl); myristolated p110(fl/fl) ROSA-gfp mouse
por: Guo, Xiaofeng, et al.
Publicado: (2019)

Extraction and Quantitative Analysis of Goat Milk Oligosaccharides: Composition, Variation, Associations, and 2′-FL Variability
por: Chatziioannou, Anastasia Chrysovalantou, et al.
Publicado: (2021)

FL studio cookbook
por: Friedman, Shaun
Publicado: (2014)

The Role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition
por: Hegar, Badriul, et al.
Publicado: (2019)

Growth and Gastrointestinal Tolerance in Healthy Term Infants Fed Milk-Based Infant Formula Supplemented with Five Human Milk Oligosaccharides (HMOs): A Randomized Multicenter Trial
por: Lasekan, John, et al.
Publicado: (2022)

Infant Formula Supplemented with Five Human Milk Oligosaccharides Shifts the Fecal Microbiome of Formula-Fed Infants Closer to That of Breastfed Infants
por: Holst, Andrea Q., et al.
Publicado: (2023)

Effects of addition of 2-fucosyllactose to infant formula on growth and specific pathways of utilization by Bifidobacterium in healthy term infants
por: Wallingford, John C., et al.
Publicado: (2022)

Growth and Tolerance of Preterm Infants Fed a New Extensively Hydrolyzed Liquid Human Milk Fortifier
por: Kim, Jae H., et al.
Publicado: (2015)

Author Correction: Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal
por: James, Kieran, et al.
Publicado: (2020)

Softer More Frequent Stools in Infants With Difficult Stooling Fed Hydrolyzed Protein Formula With Added Prebiotics: Randomized Controlled Trial
por: Fabrizio, Veronica, et al.
Publicado: (2022)

Influence of 2′-Fucosyllactose on the Microbiota Composition and Metabolic Activity of Fecal Cultures from Breastfed and Formula-Fed Infants at Two Months of Age
por: Nogacka, Alicja M., et al.
Publicado: (2021)

Safety of lacto‐N‐fucopentaose I/2’‐fucosyllactose (LNFP‐I/2’‐FL) mixture as a novel food pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2023)

Infant Fecal Fermentations with Galacto-Oligosaccharides and 2′-Fucosyllactose Show Differential Bifidobacterium longum Stimulation at Subspecies Level
por: Lindner, Cordula, et al.
Publicado: (2023)

A Partly Fermented Infant Formula with Postbiotics Including 3′-GL, Specific Oligosaccharides, 2′-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial
por: Vandenplas, Yvan, et al.
Publicado: (2020)

Chymase-Cre; Mcl-1(fl/fl) Mice Exhibit Reduced Numbers of Mucosal Mast Cells
por: Luo, Ying, et al.
Publicado: (2019)

Strangeness and heavy fl avours in Krakow
Publicado: (2011)

F.L. Shapiro: man and scientist
por: Joint Inst. Nucl. Res.
Publicado: (1998)

A Pooled Analysis of Growth and Tolerance of Infants Exclusively Fed Partially Hydrolyzed Whey or Intact Protein-Based Infant Formulas
por: Czerkies, Laura A., et al.
Publicado: (2018)

RNA-Seq analysis of obese Pdha1(fl/fl)Lyz2-Cre mice induced by a high-fat diet
por: Geng, Zhaohong, et al.
Publicado: (2022)

The DNA-recognition mode shared by archaeal feast/famine-regulatory proteins revealed by the DNA-binding specificities of TvFL3, FL10, FL11 and Ss-LrpB
por: Yokoyama, Katsushi, et al.
Publicado: (2009)

Real-world evidence study on tolerance and growth in infants fed an infant formula with two human milk oligosaccharides vs mixed fed and exclusively breastfed infants
por: Jochum, Frank, et al.
Publicado: (2023)

Confirmed Hypoallergenicity of a Novel Whey-Based Extensively Hydrolyzed Infant Formula Containing Two Human Milk Oligosaccharides
por: Nowak-Wegrzyn, Anna, et al.
Publicado: (2019)

A Randomized Controlled Trial Assessing Growth of Infants Fed a 100% Whey Extensively Hydrolyzed Formula Compared With a Casein-Based Extensively Hydrolyzed Formula
por: Fields, David, et al.
Publicado: (2016)

A perspective on partially hydrolyzed protein infant formula in nonexclusively breastfed infants
por: Vandenplas, Yvan, et al.
Publicado: (2019)

Safety of 2′‐fucosyllactose (2’‐FL) produced by a derivative strain (APC199) of Corynebacterium glutamicum ATCC 13032 as a novel food pursuant to Regulation (EU) 2015/2283
por: Turck, Dominique, et al.
Publicado: (2022)

$f_L$ measurements in B → 𝑉𝑉decays at LHCb
por: Pereiro Castro, Asier
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_us8ksbsb6v6ia3uta7iqbrf4cu